00821cam0 2200265 450 E60020006876520200505090919.020101115d1988 |||||ita|0103 baitaIT<<Le >>ombre delle ideeGiordano BrunoMilanoSpirali1988148 p.21 cmCome pensare9001LAEC000282022001 *Come pensare9Bruno, GiordanoAF0000411107045390ITUNISOB20200505RICAUNISOBUNISOB10053770E600200068765M 102 Monografia moderna SBNM100004631Si53770acquistomassimoUNISOBUNISOB20101115122327.020200505090851.0SpinosaDe umbris idearum27988UNISOB04180nam 2200745 a 450 991096767650332120251117002813.092-4-068290-2(CKB)1000000000689716(OCoLC)290609779(CaPaEBR)ebrary10227093(SSID)ssj0000283353(PQKBManifestationID)11251702(PQKBTitleCode)TC0000283353(PQKBWorkID)10248158(PQKB)10808696(MiAaPQ)EBC344010(Au-PeEL)EBL344010(CaPaEBR)ebr10227093(OCoLC)476159387(EXLCZ)99100000000068971620081107d2007 uy 0engurcn|||||||||txtccrRabies and envenomings a neglected public health issue : report of a consultative meeting, World Health Organization, Geneva, 10 January 2007 /[prepared by D. Warrell and J-M Gutierrez]1st ed.Geneva World Health Organization20071 online resource (38 p.) "This Report was developed by compiling the information provided at the WHO Consultative Meeting on Rabies and Envenomings: a Neglected Public Health Issue that took place at WHO, Geneva on 10 January 2007"--T.p. verso.92-4-156348-6 Includes bibliographical references.Intro -- CONTENTS -- SUMMARY -- INTRODUCTION -- Chapter 1 RABIES AND ENVENOMINGS: neglected diseases -- Chapter 2 EPIDEMIOLOGY: the burden of disease RABIES -- Chapter 3 PRODUCTION AND CONTROL OF THERAPEUTIC ANTISERA -- Chapter 4 DISTRIBUTION AND APPROPRIATE USE OF THERAPEUTIC ANTISERA: failure to supply those at greatest need -- Chapter 5 SCALES OF PRODUCTION: the need to strengthen capacity -- Chapter 6 PREQUALIFICATION OF ANTISERA: the way to improve access to quality and safe products -- Chapter 7 TOWARDS A GLOBAL SOLUTION: a WHO initiative to improve availability of safe antisera -- REFERENCES -- LIST OF PARTICIPANTS.The aim of this consultative meeting was to discuss strategies for improving the quality and quantity of therapeutic antisera, essential drugs for the effective treatment of suspected rabid dog bites and envenoming by snake bites and scorpion stings. Inadequacies in the efficacy, safety and production of these antisera have created a major global public health crisis, especially in Africa and Asia. Each year, millions of people are bitten by dogs or snakes or stung by scorpions and the failure to provide antisera costs at least 150,000 lives and at least as many cases of permanent physical handicap. The solution to this crisis demands an international effort to promote transfer of technology to affected countries, to improve standards through the WHO's prequalification scheme and to facilitate distribution of antisera and training of medical personnel in their optimal use.--Publisher's description.RabiesPatientsMedical careRabiesEpidemiologyRabiesChemotherapyBites and stingsPatientsMedical careBites and stingsEpidemiologyBites and stingsChemotherapyImmune serumsTherapeutic useDrug utilizationPoisonous animalsVenomPhysiological effectRabiesPatientsMedical care.RabiesEpidemiology.RabiesChemotherapy.Bites and stingsPatientsMedical care.Bites and stingsEpidemiology.Bites and stingsChemotherapy.Immune serumsTherapeutic use.Drug utilization.Poisonous animalsVenomPhysiological effect.614.563Warrell D. A283219Gutiérrez J.-M(José María)1892726World Health Organization.MiAaPQMiAaPQMiAaPQBOOK9910967676503321Rabies and envenomings4539329UNINA